-
Feb 23, 2022, 01:00
by
User Not Found
Clinical Research News | Researchers from Massachusetts General Hospital (MGH) and the University of Cyprus (Cyprus) have come up with a mathematical model that can predict treatment response for different subpopulations of patients with COVID-19 complicated by acute respiratory distress syndrome (ARDS) and determine biologic mechanisms of patient outcome.
Full story
-
Feb 21, 2022, 01:00
by
User Not Found
Clinical Research News | Ensuring the Black voice in clinical research was the focus of a panel discussion on diversity, equity, and inclusion (DE&I) at last week’s Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida. The conversation was led by two-time cancer survivor Kimberly Richardson, president of the Black Cancer Collaborative, who vividly recalls being scolded and silenced when she questioned why her slow-growing granulosa cell tumor needed to be aggressively treated with three-drug medicinal cocktail.
Full story
-
Feb 18, 2022, 17:25
by
The partnership will allow Canada’s CRO to leverage cutting-edge technology provided by the European HealthTech company, in order to innovate and optimize preclinical studies
Full story
-
Feb 18, 2022, 17:25
by
Full story
-
Feb 18, 2022, 17:25
by
Bracknell, UK – 14th February 2022: mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.
Full story
-
Feb 18, 2022, 17:25
by
For Tower sales enquiries please contact:
Nick Gilmore, Global Head of Sales & Marketing
Email: Nick.Gilmore@towercoldchain.com
For Tower media enquiries please contact:
Simon Wildash or Rhiannon Hopper, Nielsen McAllister
Tel: +44 (0)1332 293939
Email: tower@nmpr.co.uk
Full story
-
Feb 18, 2022, 17:25
by
mdgroup Appoints Steph Katz as Director of Seacole Health
Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences
Bracknell, UK: 15 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Steph Katz as Director of business subsidiary Seacole Health. Seacole Health brings mdgroup’s mobile health and clinical research staff resourcing under one roof. Steph is the ideal person to lead this exciting new venture because of her wealth of healthcare knowledge. Having started as an oncology nurse in intensive care units, Steph achieved her MSN in Nursing Education and began training research coordinators, clinical nurses and fellows. She then took on a management role, helping to develop and operationalize institutional, federal and commercial clinical research projects before pursuing an MBA.
Full story
-
Feb 18, 2022, 17:25
by
Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
Full story
-
Feb 18, 2022, 17:25
by
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
Full story
-
Feb 18, 2022, 17:25
by
Full story
-
Feb 18, 2022, 01:00
by
User Not Found
Clinical Research News | Ways to effectively engage local communities in clinical research—as trial participants, study sites, and referral partners—was a top topic of conversation at the recent Summit for Clinical Ops Executives (SCOPE) in Orlando, Fla. Karen Correa, head of global clinical operations at Takeda Pharmaceuticals, focused on tactics for educating and motivating healthcare professionals to be ongoing clinical trial referrers, while Kafayat Babajider, associate director of patient portals for Janssen Research and Development, provided a status report on its six-month-old, insights-driven My Trial Community platform.
Full story
-
Feb 16, 2022, 01:00
by
User Not Found
Clinical Research News | A leader in precision medicine and AI-enabled clinical trial enrollment for oncology patients has launched a program designed to simplify the enrollment process and open clinical trial access to all cancer patients. The goal of Massive Bio’s new 100K Singularity Program, which uses artificial intelligence (AI) and real-time access, is to transform the current clinical trial enrollment process.
Full story
-
Feb 15, 2022, 01:00
by
User Not Found
Clinical Research News | Inclusive clinical research matters to patients, shapes good science, and is imperative to business success, according to Meghan McKenzie, principal inclusion, internal partnering, in Genetech’s Chief Diversity Office. How to go about increasing diversity in clinical trials was the focus of her keynote presentation at last week’s Summit for Clinical Op Executives (SCOPE) in Orlando, Florida.
Full story
-
Feb 14, 2022, 10:28
by
User Not Found
Clinical Research News | Novartis has plans to develop one or more “connected health” solutions—a universe that includes connected devices, wearables, and software as medical devices (SaMD)—to be part of its drug program over the next five years. Its fledging digital health platform will be putting those tools in the hands of clinicians, patients, and researchers to improve the overall healthcare experience and access to trials, according to the keynote last week at the Summit for Clinical Ops Executives (SCOPE).
Full story
-
Feb 10, 2022, 14:09
by
Full story
-
Feb 10, 2022, 14:09
by
Full story
-
Feb 10, 2022, 14:09
by
Precision dosing intelligence company tripled client base, expanded oncology focus, and developed new drug models in 2021
Full story
-
Feb 10, 2022, 14:09
by
Université de Paris has installed new Bruker In Vitro Diagnostic research
(IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé
platform located in the center of Paris city, France.
Full story
-
Feb 10, 2022, 14:09
by
Germfree has announced a first of its kind, mobile platform for cell and gene (CGT) therapy.
Full story
-
Feb 10, 2022, 14:09
by
Veteran finance executive Scott Rogers appointed Saama CFO following recent $430 million dollar growth investment announcement
Full story